Cite

    Perera, V. et al. (n.d.). A randomized, cross-over study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of milvexian with single and dual antiplatelet therapy in healthy participants. European heart journal. p. . [Online].